2-(2-Cholesteroxyethoxyl)ethyl 3'-S-glutathionylpropionate and its self-assembled micelles for brain delivery: Design, synthesis and evaluation
Wang, L., Cao, Z., Wang, Z., Guo, J
Room-temperature exposure accelerates breakdown, reducing efficacy and potentially creating safety concerns if the medication has been compromised
Patients who start with gut health optimization (peptide therapy as Phase 1) consistently respond better to subsequent therapies than patients who skip that step
Dysregulation of these pathways contributes to impaired insulin secretion, altered lipid homeostasis, hyperglycemia, and metabolic dysfunction observed in obesity and type 2 diabetes [1]
Patient population stratification: which patients will benefit most (frail older, endocrine decline, metabolic syndrome)